Unparalleled Psychedelic Investing Data and Analysis

Psychedelic Invest is a resource for those looking to invest in the burgeoning psychedelic industry.

Track the entire psychedelic market

Track the entire psychedelic market

We’ve developed the first all encompassing index to track the public psychedelic marketplace.

Explore the Index

Just Some of the Data we Cover

Latest News


Braxia Scientific Introduces “Braxia Health” a Growing Network of Clinics Leading Psychedelic Research

Braxia Scientific Corp. is pleased to announce the rebranding of its growing network of research and treatment clinics to Braxia Health.

Gilgamesh Pharmaceuticals Press

Gilgamesh Pharmaceuticals Closes On $27 Million Series A Round

Quick Take: Gilgamesh Pharmaceuticals today announced the closing of a $27 million Series A round of funding led by Prime Movers Lab. In addition to Prime Movers Lab, investors included the Noetic Psychedelic Fund LP, Gron Ventures, Route 66 Ventures, JLS Fund, and Palo Santo Investors.  The company will use the investment to expand its team, continue […]

SpeakEasy Press

SpeakEasy to Enter Psychedelics Sector with Narcotics Dealers Licence

SpeakEasy Cannabis Club Ltd. announced it is 4 months into a 6-9 month application process to receiving its Narcotics Dealers License in-order to develop and standardize psilocybin cultivation.

Market Research

While All Eyes Are On the Public Markets, Private Psychedelics Companies Quietly Continue to Perform

Although there are already over 50 publicly traded psychedelics companies, there are dozens of privately funded companies that continue to advance the psychedelics industry.  These companies have collectively raised more than $700 million from investors according to CB Insights and Neuly, with the bulk primarily invested in atai Life Sciences.  Investors in these companies have […]


Psychedelic Laws in Kentucky

Kentucky—the state known for bourbon, bluegrass and fried chicken—also has a reputation for a particularly strong stance on drugs. In fact, Kentucky law specifically expresses that all of the state’s drug scheduling will correspond to scheduling applied by the federal Controlled Substances Act. As such, because psilocybin-containing mushrooms (“magic” mushrooms) and other hallucinogenic substances are […]

Novamind Press

Novamind Doubles in Size, Adds Four New Psychedelic Mental Health Clinics

Novamind Inc. announced that it will open four new Cedar Psychiatry clinics, doubling its network to eight total locations.

Core One Labs Press

Core One Labs Completes Acquisition of Akome Biotech

Core One Labs Inc. announced that it has completed the acquisition of Akome Biotech Ltd.

Explore the Psychedelic Landscape

Learn more about the psychedelic companies changing the industry.